FIRST SCHEDULE
Regulations 2(1) and 6(3) and (4)
Vaccination and approved vaccines
First column
Second column
Third column
Fourth column
Approved vaccine
Vaccination
Start
End
1.Tozinameran (Pfizer-BioNTech COVID‑19 vaccine)
(1)Two doses, administered at least 17 days apart.
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(2)For recovered individuals, one dose administered after recovery from the infection.
14th day after the first dose is administered after recovery from the infection.
365th day (including that day) after the start of the period.
 
(3)Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (1) and (2).
14th day after the last dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
2.Moderna COVID‑19 vaccine
(1)Two doses, administered at least 24 days apart.
14th day after the second dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
 
(2)For recovered individuals, one dose administered after recovery from the infection.
14th day after the first dose is administered after recovery from the infection.
365th day (including that day) after the start of the period.
 
(3)Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (1) and (2).
14th day after the last dose is administered in accordance with the second column.
365th day (including that day) after the start of the period.
[S 310/2021 wef 08/05/2021]